POSSIBLE AMELIORATIVE ROLE OF SOME COMPOUNDS ON THE SIDE EFFECTS OF ROSIGLITAZONE

EVALUATION OF THE ANTI-ISCHEMIC EFFECT OF THE PPARy AGONIST, (ROSIGLITAZONE) IN PERMANENT FOCAL CEREBRAL ISCHEMIA IN DIABETIC RATS.

Insulin sensitization via PPAR γ and glucose uptake through activation of PI3K/p-Akt signaling pathway by resveratrol in type 2 diabetic rats

A Study of The Cardio-Protective Effect of Pioglitazone on Isoprenaline- Induced Myocardial Infarction in Male Albino Rats

ROLE OF THIAZOLIDINEDIONES (TZDs) AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS AND ANTAGONOSTS IN TYPE-II DIABETES MELLITUS ON ADULT MALE ALBINO RATS

FFECT OF LOW GRADE INFLAAMMATION IN THE DEVELOPMIENT OF INSULIN RESISTANCE: A STUDY OF THE POSSIBLE EFFECTS OF ROSIGLITAZONE AND/OR ASPIRIN

THE EFFECT OF PIOGLITAZONE ON GENOMIC INSTABILITY IN INDUCED DIABETIC RATS

Comparison between the effect of the thiazolidinedione-rosiglitazone- & the sulphonylurea -gliclazide- and their combination on the liver of streptozotocin-induced diabetes melli

AMELIORATIVE EFFECT OF PIOGLITAZONE AND ROUSVASTATIN ON HFD/STZ-INDUCED HEPATIC INJURY IN RATS

The Reno-protective effect of SGLT-2 inhibitors in non-diabetic patients. A comparative review